Dr. Shen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-645-2800Fax+1 214-645-2836
Summary
- Dr. Yu-Min Shen is a hematologist based in Dallas, TX, with subspecialties in clotting disorders, hemophilia, and bleeding disorders. He completed his fellowship in Hematology and Medical Oncology and his residency in Internal Medicine at the University of Texas Southwestern Medical Center. Dr. Shen's expertise includes platelet disorders, thrombophilias, hemophilia, and bleeding disorders. He has contributed to several publications, including on topics such as hyperhemolysis syndrome and immune thrombotic thrombocytopenic purpura. He has participated in clinical trials such as those focused on thrombus removal. He received CMS Meaningful Use Stage 1 Certification from EpicCare Ambulatory EMR in 2012.
Education & Training
- University of Texas Southwestern Medical CenterFellowship, Hematology and Medical Oncology, 2001 - 2004
- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1995 - 1998
- University of California San Diego School of MedicineClass of 1995
Certifications & Licensure
- TX State Medical License 1997 - 2026
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis Start of enrollment: 2009 Nov 01
Publications & Presentations
PubMed
- How do we manage hyperhemolysis syndrome.Brian D Adkins, Samer Z Kaylani, Alecia Nero, Ibrahim F Ibrahim, Yu-Min Shen
Transfusion. 2024-10-01 - 5 citationsPhase II trials of zilucoplan in paroxysmal nocturnal hemoglobinuria.Austin G Kulasekararaj, Anna-Elina Lehtinen, Cecily Forsyth, Shreyans Gandhi, Morag Griffin
Haematologica. 2024-03-01 - 4 citationsBortezomib in relapsed/refractory immune thrombotic thrombocytopenic purpura: A single-centre retrospective cohort and systematic literature review.Nicholas C J Lee, Sean Yates, Siayareh Rambally, Ravi Sarode, Ibrahim F Ibrahim
British Journal of Haematology. 2024-02-01
Professional Memberships
- Member
- Member
- International Society of Thrombosis and HemostasisMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: